top of page


Dear Colleague,


It is our pleasure to invite you to attend the 2nd International Diabesity and Metabolic Surgery Summit (IDMSS) that will be held on October 25-27, 2022 in the beautiful city of Tel Aviv, Israel. As we are sure you are well aware, Diabetes and Obesity are related diseases that result in significant morbidity and mortality. Once considered afflictions of the developed world, they have become twin endemics throughout the world and across all cultures and economic conditions.  The cost to care for patients who suffer from obesity, diabetes or both is sobering. 


At present, metabolic/bariatric surgery has been demonstrated to be the most effective treatment option that can dramatically improve several metabolic disorders and also result in meaningful and sustainable weight loss. It has been observed over many decades that bariatric surgical procedures will not only reduce patient weight but also improve metabolic disorders such as type 2 diabetes mellitus.  Additionally, the improvement observed in the metabolic diseases is in part independent of weight loss involving mechanisms of action other than calorie restriction or malabsorption.  Therefore, a better understanding of the mechanisms of action of these procedures enables us to investigate the full potential to create even more effective treatments and procedures, vital to controlling the Diabesity pandemic.      

The focus of our forthcoming IDMSS 2022 will be the relationship between obesity and type 2 diabetes and their associated complications and the beneficial results obtainable from metabolic/bariatric surgery.  This Summit is therefore vital to increase the international knowledge of these procedures and stimulate the investigation and development of new and more effective treatments.  The Summit will bring together many of the world experts in the fields of metabolic surgery and medicine.  A wide range of related topics will be presented, discussed and debated.  The range and scope of the program are a must for all clinicians caring for patients suffering from metabolic diseases. 


The Summit includes didactic state-of-the-art presentations, debates, panel discussions, and a best paper presentation contest.  There will also be ample time to interact with the faculty and the industry partners with interest in metabolic procedures. 


It is only fitting to hold such a high-tech conference in a country known for innovation and creating new technologies. In addition, Tel-Aviv is a busy metropolis, which invigorates its visitors with a unique energetic atmosphere, exotic markets, nonstop active nightlife, golden beaches and fantastic restaurants. Tel-Aviv is also the country's cultural center, a home of a wide variety of museums, galleries, theaters and concert halls. Tel-Aviv is located in the center of the country.  It is easy to get to Tel-Aviv from Ben Gurion Airport and it is less than an hour car/bus ride from Jerusalem.  Participants will be encouraged to spend a few extra days in Israel to travel and sight-see.


Please join us for this unique conference.



Scott A. Shikora, MD, FACS, FASMBS   

Nasser Sakran, MD

bottom of page